View Rule
| View EO 12866 Meetings | Printer-Friendly Version Download RIN Data in XML |
| HHS/FDA | RIN: 0910-AJ15 | Publication ID: 2026 |
| Title: ●Update 21 CFR 610.13(b) (Rabbit Pyrogen Testing) | |
|
Abstract:
The Food and Drug Administration is updating 21 CFR 610.13(b) to include established in vitro general standards for the detection of pyrogens including bacterial endotoxin in drug products. |
|
| Agency: Department of Health and Human Services(HHS) | Priority: Substantive, Nonsignificant |
| RIN Status: First time published in the Unified Agenda | Agenda Stage of Rulemaking: Proposed Rule Stage |
| Major: No | Unfunded Mandates: No |
| EO 14192 Designation: Deregulatory | |
| CFR Citation: 21 CFR 610.13 | |
| Legal Authority: 21 U.S.C. 321 21 U.S.C. 331 21 U.S.C. 351, 352, and 353 21 U.S.C. 355 21 U.S.C. 360 21 U.S.C. 360c and d 21 U.S.C. 360h and i 21 U.S.C. 371 and 372 21 U.S.C. 374 21 U.S.C. 381 42 U.S.C. 216 42 U.S.C. 262 and 263 42 U.S.C. 263a 42 U.S.C. 264 | |
|
Legal Deadline:
None |
||||||
Timetable:
|
| Regulatory Flexibility Analysis Required: No | Government Levels Affected: None |
| Federalism: No | |
| Included in the Regulatory Plan: No | |
| RIN Data Printed in the FR: No | |
|
Agency Contact: Phillip Kurs Acting Associate Director for Policy Department of Health and Human Services Food and Drug Administration 10903 New Hampshire Avenue, WO Building 71, Room 7217, Silver Spring, MD 20993 Phone:240 402-0467 Email: phillip.kurs@fda.hhs.gov |
|
An official website of the United States government




